HealthSwitzerlandOct 27, 2026

Atlas Bio raises $12.5M (Switzerland, Oct 2026)

$12.5M
$12.5M

Find the investors funding Health rounds

326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.

Find your investors →
Headline

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing - Tech.eu

About

Atlas Bio is a Swiss startup focused on improving drug development by tackling the high failure rate and aiming to move beyond animal testing. This funding round will support their efforts to create more effective and ethical pharmaceutical research processes.

Article summary

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing  Tech.eu

Investors
Related rounds
Oct 22, 2026Enact$30.0MPre-seedSwitzerland
Oct 19, 2026Nouscom$120.0M—Switzerland
Oct 09, 2026Klarent$7.7MSeedSwitzerland
Oct 09, 2026Besso$4.5M—Switzerland

12,000 investors back startups in Switzerland

You just read who funded Atlas Bio. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.

Free account: 15 investor contact unlocks a month, no card required.

About the investors in Switzerland